News
-
A future with tailored therapy for patients with atherosclerosisGrant awarded 11 September 2025Personalised treatment for patients with atherosclerosis. That is what the researchers of the AtheroNeth consortium are working towards. The Dutch Hea...
-
European Proof of Concept grants for two Leiden researchers14 July 2025Two Leiden researchers have been awarded ERC Proof of Concept grants. These grants, each worth EUR 150,000, will help the grantees in their efforts to...
-
A smarter way to search for antibiotics16 June 2025Bacteria carry countless hidden treasures in their DNA: fragments that could hold the key to new medicines. But how do you pick out the most promising...
-
Leiden-developed drug candidate ready for final clinical trial phaseImpact 27 May 2025Bringing your drug candidates to patients is what many academic chemists dream about, but the road to this goal is long and bumpy. Now, Leiden small m...
-
Over a million euros for two studies on solutions to antimicrobial resistanceHealthcare 18 March 2025Two consortia led by Leiden researchers have been awarded over one million euros by the Dutch Research Council and the Ministry of Health, Welfare and...
-
These were Leiden University’s interdisciplinary milestones of 202417 December 2024Connecting scientific fields, enhancing research and teaching, and providing innovative solutions to complex social issues: that is the idea behind in...
-
Antibodies against rheumatic diseases tested directly on patients20 November 2024Leiden Professor of Translational Rheumatology Hans Ulrich Scherer has one foot in the clinic, where he helps patients, and the other in the lab, wher...
-
The Nobel Prize in Chemistry went to an AI model (and rightly so)24 October 2024Not experiments and lab coats, but computers and artificial intelligence: this year's Nobel Prize in Chemistry went to the inventors of the groundbrea...
-
During the next pandemic, this mathematical model will speed up the search for treatment09 September 2024Do you recall all those drugs that were hastily proposed as potential treatments for COVID-19? In the event of a future pandemic, the goal is to offer...
-
RARE-NL: LUMC joins consortium to find treatments for rare diseases26 August 2024RARE-NL, a new collaboration between university hospitals, hopes to find treatments for rare diseases. Professor Teun van Gelder is representing the L...
-
Oncode Accelerator launched: patients at the centre of innovative cancer drug development08 September 2023Providing each cancer patient with the right treatment remains a challenge. Oncode Accelerator aims to change this by innovating the way we develop ca...
-
In conversation with the head of the rodent facility06 September 2023Before patients can take a pill, scientists often spend years in the lab developing and testing a candidate drug. That often includes experiments with...
-
Artificial intelligence as the co-pilot for drug discovery23 May 2023There are more molecules that could conceivably be candidate drugs than there are stars in the universe. How can we ever efficiently identify those mo...
-
Horizon Europe grant for research into personalised treatment for high blood pressure18 April 2023Professor Thomas Hankemeier and his international research team HYPERMARKER have received a 10m-euro grant from Horizon Europe and UK Research and Inn...
-
LUMC researchers: matching medication to DNA leads to 30% fewer side effects03 February 2023According to an international group of researchers led by Leiden University Medical Center (LUMC), patients experience 30% fewer serious side effects ...